Boron neutron therapy for recurrent head and neck cancer
Part of Cancer clinical trials.
This trial tests a new type of radiation therapy (boron neutron capture therapy) combined with two drugs for people whose head or neck cancer has returned and standard treatments have failed. It aims to see if this combination can shrink tumors and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have head or neck cancer that has come back or spread to nearby lymph nodes.
- Previous standard treatments (like radiation or chemo) did not work or you couldn't tolerate them.
- You must be in good enough health to carry out daily activities (ECOG performance status 0-1 or 2).
- You must not have had other cancer treatments (except surgery) in the last 4 weeks, and radiation to the treatment area in the last 3 months.
- You are able to use effective birth control during the study and for 6 months after.
- You have no serious heart, lung, or immune system problems, and no history of drug or alcohol abuse.
- You have no allergies to the study drug ingredients, and no metal implants in the area to be treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of radiation therapy called BNCT (boron neutron capture therapy) for head and neck cancers that have come back and cannot be removed by surgery. It may be an option for patients who have already had radiation and cannot receive standard chemotherapy.
This trial tests a new combination for people whose head and neck cancer has come back after prior radiation. You'll receive an immunotherapy drug (pembrolizumab) plus radiation, then surgery. The goal is to see if this approach can improve how well surgery works.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This trial tests a precise type of radiation called stereotactic radiosurgery for people with head or neck tumors. It may be an option for those who need radiation or chemoradiation as their main treatment or after surgery.
This trial tests a type of radiation therapy called BNCT (boron neutron capture therapy) for people with head and neck cancer that cannot be surgically removed. It may be an option if you have already had radiation or chemo and have no distant spread of cancer.
This trial tests a special type of radiation therapy called boron neutron capture therapy (BNCT) for people with high-grade malignant brain tumors. It aims to see if BNCT is safe and effective for tumors that have not been treated or have come back after standard treatments.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.